Welcome Center  |   Log In  |   Register  |   Follow Us  Facebook  Twitter Google Plus

More in Hematology-Oncology

Reuters Health • The Doctor's Channel Daily Newscast

Gemcitabine added to standard therapy improves survival in cervical cancer

NEW YORK (Reuters Health) – Patients with advanced cervical carcinoma have better progression-free survival when gemcitabine is added to concurrent cisplatin chemoradiotherapy and included in adjuvant therapy, an international team reports in the...

Reuters Health • The Doctor's Channel Daily Newscast

Radiation for prostate cancer increases hip fracture risk

NEW YORK (Reuters Health) – Men who receive radiation treatment for prostate cancer are at greater risk of hip fracture, a new study in the March 16 issue of Cancer reports. Based on the findings, men with prostate cancer considering their treatment...

Mutations and B-Raf protein

Cancer and Melanoma

David B. Solit, MD, Elizabeth and Felix Rohatyn Chair for Junior Faculty, Memorial Sloan-Kettering Cancer Center, discusses B-Raf, an intracellular signaling protein.B-Raf is commonly mutated in cancer, and about 8% of all human cancers have B-Raf...